ACHONDROPLASIA NATURAL HISTORY...TOPICS FOR TODAY •Discuss design of achondroplasia natural...
Transcript of ACHONDROPLASIA NATURAL HISTORY...TOPICS FOR TODAY •Discuss design of achondroplasia natural...
ACHONDROPLASIA NATURAL HISTORY:
A MULTICENTER COHORT STUDY
Julie Hoover-Fong, MD, PhD
Director, Greenberg Center for Skeletal Dysplasias
McKusick-Nathans Institute of Genetic Medicine
Johns Hopkins University
Baltimore, Maryland
DISCLOSURES
Funding for this achondroplasia natural history study was provided by BioMarin, Inc. through an Independent Research Grant. Dr. Hoover-Fong is a paid consultant to BioMarin.
These arrangements have been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies.
All images from Google Images unless otherwise noted.
TOPICS FOR TODAY
• Discuss design of achondroplasia natural history study
• Results from primary achondroplasia cohort (n = 1377)
• Demographics, anthropometry, surgical burden, sleep disordered breathing, radiographic catalogue
• Next steps in analysis
• Next steps in study expansion
STUDY TEAM
Johns Hopkins University
Baltimore, Maryland
PI: Julie Hoover-Fong, MD, PhD
Biostatistician: Chengxin Liu, MS
Study Administrator: Colleen Gioffreda, BA
Former co-ordinator: Yewande Alade, MPH
AI duPont Hospital for Children
Wilmington, Delaware
Co-PI: Michael Bober, MD, PhD
Study Coordinator: Mary Ellen Little, BSN, RN
University of Texas
Houston, Texas
Co-PI: Jacqueline Hecht, PhD
Co-Investigator: Syed Hashmi, MD, MPH
Consultant: David Rodriguez-Buritica, MD
Study Coordinator: Elena Serna
University of Wisconsin
Madison, Wisconsin
Co-PI: Janet Legare, MD
Consultant: Richard Pauli, MD, PhD
Study co-ordinators: Cory Smid, BS, Peggy Modaff, MS, CGC
Key Johns Hopkins members: John McGready, PhD and Kerry Schulze, PhD
PROBLEM & PURPOSE:
• Problem: Increased risk of adverse health outcomes related to cardiovascular disease, pain, compromised physical function and obstructive and central sleep apnea in ACHONDROPLASIA.
Natural history and interactions of risk factors poorly understood.
• Purpose: To understand natural history of achondroplasia and the health outcomes of past,current and future pharmacologic, medical and surgical interventions.
ACHONDROPLASIA
• Most common skeletal dysplasia
• 1:20,000-1:30,000
• Dwarfism in ancient Egypt, Greece, Rome, ~3,000 to ~30 BCE
• Revered by rulers, general population
Per-ni-ankh
Discovered in limestone tomb in 1989Western field of great pyramid Khufu
ACHONDROPLASIA• Cervicomedullary compression
• Spinal stenosis
• Central sleep apnea
• Obstructive sleep apnea
• Chronic otitis media, fluid with speech delay and hearing deficit
• Genu varus, tibial bowing
• Long track signs
• Rhizomelia
• Thoracolumbar kyphosis
• Fibroblast growth factor receptor 3 FGFR3• 99% with same Gly380Arg substitution; <1% with Gly375Cys • Autosomal dominant• 100% penetrant• 80-90% spontaneous mutation • 1-2% risk gonadal mosaicism • Advance paternal age
OVERVIEW: ACHONDROPLASIA NATURAL HISTORY STUDY
• All available medical records
• Achondroplasia (molecular or clinical)
• Saw clinical geneticist, 1957-2017
• 2 year, multi-center, retrospective and cross-sectional data collection
with prospective functionality
• Research Electronic Data Capture (REDCap) system
Web-based database, hosted at Johns Hopkins Biostatistics Center
(JHBC) on servers at Data Info Services Core (DISC)
4 primary study domains
1. Anthropometry
2. Surgical burden
3. Sleep disordered breathing
4. Image catalogue
Lots of data…
Long road between ‘data in
hand’ and results…
Tempting…
STUDY DESIGN
Phase 1:
Retrospective and cross-
sectional data collection
REALIGN DATA FROM BIRTH
TIME
Birth 10 yrs 20 yrs 30 yrs 40 yrs 50 yrs
Example:
5 subjects
4 at least 10 years old
2 had lower extremity osteotomies
Compare osteotomy versus not:
• Why surgery?
• Degrees varus?
• Pain?
• Weight?
• Physical function now?
Birth 5 yrs 10 yrs 15 yrs 20 yrs 25 yrs
TIME
duPont
Hopkins
Texas
Wisconsin
REALIGN DATA FROM BIRTH
TO COMPARE SITES
1970s 1980s 1990s 2000s 2010s
EXAMINE BY BIRTH COHORT/DECADE,
2 of 16 had MRIs 6 of 7 had MRIs
How often were
MRIs of the
foramen magnum
done in the 1980s
versus 2000s?
TO ASSESS SECULAR TRENDS
STUDY DESIGN
Phase 1:
Retrospective and cross-
sectional data collection
1,377 SUBJECTS
PRIMARY
ACHONDROPLASIA
COHORT
And identify patients from
natural history study for
Phase 2 prospective study
IDENTIFIED ~ 500
‘ACTIVE’ SUBJECTS
FOR PROSPECTIVE
STUDY
STUDY DESIGN
Phase 2:
~ 500 subjects from Primary
Achondroplasia Cohort will be
studied prospectively
Lost to followup
Opts out of prospective studies
1. Craniofacial structure
2. Metabolism
3. Neurocognition
4. Pain & physical
function related to
osteotomies & spine
surgery
NOW THE FUN STUFF! DATA!
DEMOGRAPHICS
POPULATION
INHERITANCE & DIAGNOSIS
* Prenatal diagnosis began in the 1980s
** ~70% of unknown age at diagnosis was from archive records before 1990
4 PRIMARY STUDY DOMAINS
1. ANTHROPOMETRY
2. SURGICAL BURDEN
3. SLEEP DISORDERED BREATHING
4. RADIOLOGY CATALOGUE
ANTHROPOMETRY
Height velocity decreases earlier in females than males.
This is reflected subtly in the height-for-age curves above.
Data from this cohort indicates minimal linear growth continues
in females until 21.7 years; 19.3 years in males.
ACHONDROPLASIA HEIGHT
He
igh
t ve
loc
ity (
cm
/yr)
EARLIER ACHONDROPLASIA COHORT (N= 202) AJCN, 2008
No height velocity ‘bump’ with puberty.
Average height velocity was steady at ~4 cm/yr from ~2 years of age on
in males and females.
HEIGHT VELOCITY
Average stature males:
Median peak height velocity
9.3 cm/yr at 13.5 years.
Average stature females:
Median peak height velocity
8.3 cm/yr at 12 years.
Until 10 years,
average stature
5th %ile velocity
=
Achondroplasia
mean velocity
SURGICAL BURDEN
SURGICAL BURDEN 5 categories:
ENT: tonsillectomy,
adenoidectomy, tubes,
tympanoplasty
Brain: VP shunt, VPS revision,
ventriculostomy
Foramen: cervicomedullary
decompression, cervical
decompression, C-spine
fusion
Spine: C/T/L laminectomy,
fusion, kyphosis
Extremity: Osteotomies
SURGICAL BURDEN
Average stature Achondroplasia
CERVICOMEDULLARY DECOMPRESSION
FOR CERVICOMEDULLARY COMPRESSION
OSTEOTOMTIES FOR LOWER
EXTREMITY MALALIGNMENT
PROXIMAL TIBIAL OSTEOTOMIES
DISTAL TIBIAL OSTEOTOMIES & GROWTH MODULATION
Films from Dr. Will Mackenzie and Dr. Michael Bober
DISTAL TIBIAL AND FIBULAR OSTETOTOMIES, EXTERNAL FIXATION
DIFFERENT WAY TO EXAMINE OSTEOTOMIES OVER TIME
PERSON YEARS
Survival analysis (free of surgery) reveals probability of lower extremity osteotomy at 10 years of age is 12.0%; at 20 years it is 25.3%
Subjects w/ PE tubes,N (% of total)
Subjects with T&A, N (% of total)
duPont 240 (62.3) 215 (55.8)
JHU 130 (43.2) 112 (37.2)
Texas 67 (30.7) 59 (27.1)
Wisc 334 (70.6) 349 (73.8)
Total 771 (56.0) 735 (55.3)
TYPMANOSTOMY TUBES AND
TONSILLECTOMY / ADENOIDECTOMY
SLEEP DISORDERED BREATHING
RADIOGRAPHIC CATALOGUE
SUMMARY OF PROGRESS
• 1st multi-center natural history study of achondroplasia
• Novel observations about growth velocity, final adult height, surgical burden and sleep disordered breathing
• Now examining interactions among study domains
• This cohort may serve as controls against subjects treated with novel pharmacologic, medical and surgical interventions
• Active subjects can participate in prospective studies pertaining to craniofacial structure, neurocognition, metabolism, foramen magnum
NEXT STEPS
• Complete descriptive analysis of retrospective data from 1377 subjects in Primary Achondroplasia Cohort
• 9 manuscripts, multiple presentations
• Begin prospective study of Active subcohort
• Craniofacial structure, metabolism, neurocognition, pain & physical function related to osteotomies, spine surgery
• Secure funding for phase 3 (RDN?)
• Biorepository (i.e. WES, biomarker identification)
• More study sites
• More dysplasias
ADDITIONAL COMMENTS ABOUT THE DATA ‘IN HAND’
1. Combine data across domains to learn clues about cause and effect for prospective studies
COMBINING DATA ACROSS DOMAINS
• Pre- and post-operative studies
• 239 subjects had CMD
• 130 had > 1 sleep study
• 190 had MRI
• Can examine sleep study for central apnea and MRI for size FM before and after CMD.
• 753 adenotonsillectomies in 598 subjects
• 388 had sleep studies.
• Can examine effect of surgery at different ages, severity of OSA.
• Co-morbidities prompting surgery (e.g. weight, pain); when is best timing for X procedure?
ADDITIONAL COMMENTS ABOUT THE DATA ‘IN HAND’
1. Combine data across domains to learn clues about cause and effect for prospective studies
2. Can we formulate recommendations for better treatment?
RECOMMENDATIONS FOR BETTER TREATMENT
• Is patient better or worse after surgery?
• How bad should lower extremity malalignment be before operating?
• Should surgery be performed before the patient is in severe pain? (i.e. prophylactically)
• Can we predict who will need X surgery (who won’t)?
• Which is more of a burden: 2 lower extremity surgeries or 1 back surgery? Difficult to compare
ADDITIONAL COMMENTS ABOUT THE DATA ‘IN HAND’
1. Combine data across domains to learn clues about cause and effect for prospective studies
2. Can we formulate recommendations for better treatment?
3. Recognize huge phenotypic variability among subjects, yet all have same mutation
**Golden opportunity to study genetic and environmental modifiers of the phenotype
BACKUP
86 individuals had an adult height percentile and height data between 8 and 20 years.
The mean difference in adult height percentile and average height percentile between 8 and 20 years of
age is 0.012 with 95% CI (-0.04, 0.0712).
On average there is no difference in the final adult height percentile and that before 20 years of age.
Your eyes are very good!
9 of the 86 have a diff > .25 in absolute values!
John
Mean of height percentiles for 8-20 years
Me
an
ad
ult h
eig
ht
pe
rce
ntile
s